ArticleNutrition & metabolism2025
The effect of multiple micronutrients supplementation on preventing anemia during pregnancy: a retrospective cohort study.
Article in Nutrition & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo evaluate the efficacy of Multiple Micronutrient (MMN) Supplements during pregnancy in reducing the risk of anemia among pregnant women.
methodA retrospective cohort study was conducted with the supplement of Folic Acid (FA) only and FA plus MMN groups. Data was collected through questionnaires during the first prenatal visit. Hemoglobin levels were extracted from the Laboratory Information System. A total of 4,239 pregnant women who were admitted to Beijing Haidian Maternal & Child Health Hospital between May 2017 and November 2020 was evaluated. Chi-square tests and log-binomial regression were conducted to evaluate the relative risks (RRs) of two groups on the reduction of anemia during pregnancy.
resultsThe supplement of MMN was found to significantly decrease the risk of anemia in the later stages of pregnancy. Focusing on the third trimester specifically, the crude RR and adjusted RR were 0.891 and 0.844 respectively. In the second and third trimester of pregnancy, a sufficient monthly intake frequency of MMN(≥ 24 pills) is associated with a lower relative risk of anemia, with a value of 0.897 and 0.809 compared to the group supplement FA only.
conclusionsThe supplement of MMN has been correlated with a reduced risk of anemia in the second and third trimesters of pregnancy. But the efficacy was limited in the first trimester. Frequent and early initiation of supplementation with FA and MMN pills is associated with a more significant reduction in the risk of anemia compare to group supplement of FA only.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.